mrd focus: why measurable residual disease testing is the future
Published 6 years ago • 561 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
2:22
next-generation methodologies: the future for mrd monitoring in all?
-
2:18
the utility of measurable residual disease (mrd) assessment in acute myeloid leukemia (aml)
-
3:28
bringing minimal residual disease (mrd) measurement to the clinic
-
1:02
challenges with measurable residual disease (mrd) assessment in acute myeloid leukemia (aml)
-
7:39
understanding mrd
-
7:42
what is mrd?
-
4:35
flow cytometry animation
-
1:47
the importance of minimal residual disease in all
-
2:05
using mrd negativity to measure depth of response & to discontinue treatment in multiple myeloma
-
4:30
measurable residual disease in aml
-
4:35
learn about measurable residual disease (mrd)
-
1:46
standardization mrd monitoring in clinical trials
-
2:51
profiling deep minimal residual disease in multiple myeloma
-
2:25
master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm
-
1:05
measurable residual disease - what is mrd and why is it important
-
0:46
the importance of mrd assessment in all phases of all treatment
-
1:41
novel technologies to detect minimal residual disease (mrd)
-
1:23
the value of mrd as a marker for disease eradication in aml
-
22:56
measurable residual disease (mrd) in aml and all
-
2:18
new applications for mrd measurement in myeloma: mrd 'over time'
-
3:40
what’s new in minimal residual disease (mrd) detection in myeloma?